ReviewFrontiers in oncology2022

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.

Domenica Lorusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.